Derek W. Gilroy

30.1k total citations · 10 hit papers
143 papers, 17.2k citations indexed

About

Derek W. Gilroy is a scholar working on Immunology, Pharmacology and Molecular Biology. According to data from OpenAlex, Derek W. Gilroy has authored 143 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Immunology, 44 papers in Pharmacology and 36 papers in Molecular Biology. Recurrent topics in Derek W. Gilroy's work include Inflammatory mediators and NSAID effects (39 papers), Immune Response and Inflammation (33 papers) and Eicosanoids and Hypertension Pharmacology (30 papers). Derek W. Gilroy is often cited by papers focused on Inflammatory mediators and NSAID effects (39 papers), Immune Response and Inflammation (33 papers) and Eicosanoids and Hypertension Pharmacology (30 papers). Derek W. Gilroy collaborates with scholars based in United Kingdom, United States and Ireland. Derek W. Gilroy's co-authors include D. A. Willoughby, Toby Lawrence, Paul Colville‐Nash, James N. Fullerton, Charles N. Serhan, Christopher D. Buckley, Melanie Stables, Mauro Perretti, Adriano G. Rossi and Justine Newson and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Derek W. Gilroy

141 papers receiving 16.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic inflammation in the etiology of disease across the life span

2019 3.0k citations David Furman, Judith Campisi et al. Nature Medicine profile →
Inducible cyclooxygenase may have anti-inflammatory properties

1999 1.1k citations Derek W. Gilroy, Paul Colville‐Nash et al. Nature Medicine profile →
Resolution of in flammation: state of the art, definitions and terms

2007 862 citations Derek W. Gilroy et al. profile →
Anti-inflammatory lipid mediators and insights into the resolution of inflammation

2002 725 citations D. A. Willoughby, Derek W. Gilroy et al. profile →
Resolution of inflammation: a new therapeutic frontier

2016 688 citations James N. Fullerton, Derek W. Gilroy profile →
Possible new role for NF-κB in the resolution of inflammation

2001 643 citations Derek W. Gilroy, Paul Colville‐Nash et al. Nature Medicine profile →
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation

2014 640 citations Derek W. Gilroy et al. profile →
The fate and lifespan of human monocyte subsets in steady state and systemic inflammation

2017 639 citations James N. Fullerton, Alexander A. Maini et al. profile →
Inflammatory Resolution: new opportunities for drug discovery

2004 621 citations Derek W. Gilroy et al. profile →
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis

2021 194 citations Derek W. Gilroy et al. profile →

Peers

Countries citing papers authored by Derek W. Gilroy

Since Specialization

Citations

This map shows the geographic impact of Derek W. Gilroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek W. Gilroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek W. Gilroy more than expected).

Fields of papers citing papers by Derek W. Gilroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek W. Gilroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek W. Gilroy. The network helps show where Derek W. Gilroy may publish in the future.

Co-authorship network of co-authors of Derek W. Gilroy

This figure shows the co-authorship network connecting the top 25 collaborators of Derek W. Gilroy. A scholar is included among the top collaborators of Derek W. Gilroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek W. Gilroy. Derek W. Gilroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Challenges of monocyte HLA-DR targeted immunomodulation in sepsis—a prospective observational cohort study 2026 ·Frontiers in Immunology ·Timothy Arthur Chandos Snow, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Julia Flint, (unknown), (unknown), Derek W. Gilroy, (unknown)	0
2	Review of methodology and re‐analysis of lipidomic data focusing on specialised pro‐resolution lipid mediators (SPMs) in a human model of resolving inflammation 2024 ·International Journal of Experimental Pathology ·Natalie Homer, Ruth Andrew, Derek W. Gilroy	1
3	Neutrophils infiltrate sensory ganglia and mediate chronic widespread pain in fibromyalgia 2023 ·Proceedings of the National Academy of Sciences ·Sara Caxaria, (unknown), (unknown), (unknown), B.L. Thomas, (unknown), Francesco Dell’Accio, Simon Yona, Derek W. Gilroy, Mathieu-Benoı̂t Voisin, John N. Wood, Shafaq Sikandar	46
4	Home-built environment interventions and inflammation biomarkers: a systematic review and meta-analysis protocol 2022 ·BJGP Open ·(unknown), E Chrysikou, Larissa Nekhlyudov, Derek W. Gilroy, José M Ordóñez-Mena	3
5	Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly 2020 ·Nature Immunology ·Roel P. H. De Maeyer, (unknown), (unknown), Olivia V. Bracken, Oliver Devine, Daniel R. Goldstein, Mohib Uddin, Arne N. Akbar, Derek W. Gilroy	128
6	Lipid mediators in immune regulation and resolution 2019 ·British Journal of Pharmacology ·Derek W. Gilroy, David Bishop‐Bailey	65
7	Chronic inflammation in the etiology of disease across the life span breakdown → 2019 ·Nature Medicine ·David Furman, Judith Campisi, Eric Verdin, Pedro Carrera‐Bastos, Sasha Targ, Claudio Franceschi, Luigi Ferrucci, Derek W. Gilroy, Alessio Fasano, Gary W. Miller, Andrew H. Miller, Alberto Mantovani, Cornelia M. Weyand, Nir Barzilai, Jörg J. Goronzy, Thomas A. Rando, Rita B. Effros, Alejandro Lucía, Nicole Kleinstreuer, George M. Slavich	3020
8	Prolonged immune alteration following resolution of acute inflammation in humans 2017 ·PLoS ONE ·Madhur P. Motwani, Justine Newson, (unknown), (unknown), Romain A. Colas, Jesmond Dalli, Derek W. Gilroy	31
9	Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation 2016 ·Journal of Visualized Experiments ·James N. Fullerton, (unknown), Roel P. H. De Maeyer, Alexander A. Maini, Derek W. Gilroy	6
10	CYP450-derived oxylipins mediate inflammatory resolution 2016 ·Proceedings of the National Academy of Sciences ·Derek W. Gilroy, Matthew L. Edin, Roel P. H. De Maeyer, Jonas Byström, Justine Newson, Fred B. Lih, Melanie Stables, Darryl C. Zeldin, David Bishop‐Bailey	118
11	Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice 2011 ·Blood ·Ramona S. Scotland, Melanie Stables, Shimona Madalli, Peter H. Watson, Derek W. Gilroy	235
12	A New Strategy for the Identification of Novel Molecules with Targeted Proresolution of Inflammation Properties 2009 ·The Journal of Immunology ·(unknown), Justine Newson, Vera L.F. Silveira, Stuart Farrow, Derek W. Gilroy, Jonas Byström	84
13	Nonresolving Inflammation in gp91 phox −/− Mice, a Model of Human Chronic Granulomatous Disease, Has Lower Adenosine and Cyclic Adenosine 5′-Monophosphate 2009 ·The Journal of Immunology ·Ravindra Rajakariar, Justine Newson, Edwin K. Jackson, (unknown), Andrew Smith, Farooq Rahman, Muhammad Yaqoob, Derek W. Gilroy	24
14	Sensitive and Rapid Molecular Detection Assays for Salmonella enterica Serovars Typhimurium and Heidelberg 2009 ·Journal of Food Protection ·(unknown), F. Jerry Reen, (unknown), Jonathan G. Frye, E. Fidelma Boyd, Derek W. Gilroy	24
15	Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP 2008 ·Blood ·Jonas Byström, Ian Evans, Justine Newson, Melanie Stables, Iqbal Toor, Nico van Rooijen, Mark Crawford, Paul Colville‐Nash, Stuart Farrow, Derek W. Gilroy	259
16	Low-dose acetylsalicylic acid inhibits the secretion of interleukin-6 from white adipose tissue 2008 ·International Journal of Obesity ·Nicola Ogston, Kalypso Karastergiou, Mohammad Javad Hosseinzadeh‐Attar, Rahul Bhome, R. Madani, Melanie Stables, Derek W. Gilroy, Pavel Flachs, Michal Hensler, Ján Kopecký, Vidya Mohamed‐Ali	15
17	Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity 2006 ·Proceedings of the National Academy of Sciences ·Seema Trivedi, Justine Newson, Ravindra Rajakariar, Thomas S. Jacques, Robert Hannon, Yoshihide Kanaoka, Naomi Eguchi, Paul Colville‐Nash, Derek W. Gilroy	109
18	Evaluation of surimi, fat and water content in a low/no added pork sausage formulation using response surface methodology 2003 ·Meat Science ·(unknown), Derek W. Gilroy, John F. Kerry, D.J. Buckley, Joseph P. Kerry	84
19	Nitric Oxide Synthase Inhibitors Have Opposite Effects on Acute Inflammation Depending on Their Route of Administration 2001 ·The Journal of Immunology ·Mark J. Paul‐Clark, Derek W. Gilroy, Dean Willis, D. A. Willoughby, Annette Tomlinson	65
20	The effects of harrowing on oxytetracycline resistance in marine sediment micro-organisms beneath a salmon farm 1995 ·Bulletin of the European Association of Fish Pathologists ·Joe P. Kerry, Derek W. Gilroy, Maura Hiney, Rosie Coyne, Pete Smith	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact